Retaglutide is a cutting-edge GLP-1 receptor agonist currently under investigation for the control of obesity. This drug works by stimulating the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring https://sairarpdi458722.iyublog.com/37867453/retaglutide-a-promising-glp-1-receptor-agonist